Ventio

Ventio

English

How and why implement ISO27001?

Committed to a quality approach involving information security management, Ventio has decided to follow the ISO 27001 standard, considered to be the benchmark in this field. Noémie Vang is a certified ‚Lead Implementer‘, enabling the formal implementation of this standard … Read More

[Revue Polytechnique]

Imaging services at the cutting edge of innovation and with very high added value In March 2024 issue, “La Jaune & La Rouge” magazine interviewed our CEO Ludovic de Rochefort about Ventio’s expertise, the importance of sharing healthcare data to … Read More

SFRMBM 2023

Miguel Guevara1, Davy Cam4, Jacques Badagbon4, Stéphane Roche4, Michel Bottlaender3, Yann Cointepas1,2, Jean-François Mangin1,2, Ludovic de Rochefort4 and Alexandre Vignaud1,2 1 CNRS BAOBAB UMR9027 Gif-Sur-Yvette, France ; 2 CEA NeuroSpin, Gif-Sur-Yvette; 3 UNIACT, NeuroSpin, CEA, Gif-sur-Yvette, France ; 4 VENTIO, Marseille, France … Read More

Ventio joins Medicen for the development of innovative health technologies

Ventio joins Medicen for the development of innovative health technologies. Medicen is 120 companies in the Innovation-Diagnostics cluster, a “Core TEAM Imaging” working group, and a recent “Brain-STORM” call for interest for transversal research projects in the field of neurodegenerative … Read More

SFRMBM 2023

Ahead : We are sponsor of the 2023 congress of the French Society of Magnetic Resonance and Medical Biology (Société Française de Résonance Magnétique et de Biologie Médicale, SFRMBM). We will be present during the 3 days of this event. … Read More

QMRLucca 2022

QSM4SENIOR: Quantitative susceptibility mapping in the aging of the healthy brain. Miguel Guevara1,2, Davy Cam3, Jacques Badagbon3, Michel Bottlaender2, Yann Cointepas1,2, Jean-François Mangin1,2, Ludovic de Rochefort3 and Alexandre Vignaud1,2 Joint Workshop on MR phase, magnetic susceptibility and electrical properties mapping, … Read More

MEDICEN

Pôle de compétitivité santé MEDICEN

World Alzheimer’s Day 2022

Ventio participates to the follow-up of Alzheimer’s disease patients by offering a patented, innovative and quantitative technology for the follow-up of neuronal lesions by cerebral imaging: the Quantitative Susceptibility Mapping (QSM) technology.   Ventio, with the QSM technology, is alongside … Read More

Marseille Innovation

Institut Régional des Chefs d’Entreprise